RZRong-Sheng Zhao

Rong-Sheng Zhao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Rong-Sheng Zhao has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • Ai-Hua Zhang

    Department of Nephrology, Xuanwu Hospital, Capital Medical University

    1 shared publication
  • Dan-Dan Li

    Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Science, Peking University BeijingPeople’s Republic of China; Department of Pharmacy, Peking University Third Hospital BeijingPeople’s Republic of China

    1 shared publication
  • Hong-Gang Nie

    Key Laboratory of Bioorganic Chemistry and Molecular Engineering of Ministry of Education, Institute of Analytical Chemistry, College of Chemistry and Molecular Engineering, Peking University BeijingPeople’s Republic of China

    1 shared publication
  • Min-Hua Fan

    Department of Nephrology, Peking University Third Hospital BeijingPeople’s Republic of China

    1 shared publication
  • Qiong Bai

    Department of Nephrology, Peking University Third Hospital BeijingPeople’s Republic of China

    1 shared publication
  • Song Wang

    Department of Nephrology, Peking University Third Hospital BeijingPeople’s Republic of China

    1 shared publication

Latest Publications

  • Changes of urinary phospholipids in the chronic kidney disease patients

    by Wen-Ling Yang, Qiong Bai, Dan-Dan Li, Ta-La A, Song Wang, Rong-Sheng Zhao, Hong-Gang Nie, Ai-Hua Zhang, Tao Wang, Min-Hua Fan

    Objective: To evaluate whether urinary phospholipids could be regarded as biomarkers of chronic kidney disease. Materials and methods: Thirteen healthy volunteers and 26 consecutive chronic kidney disease patients were included. Urinary phospholipids were quantified by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry. Results: Urinary phosphatidylcholines concentrations (PC 16:0/16:0, 16:0/22:3, 16:0/18:1 and 16:0/18:2) were significantly higher both in glomerulonephritis group (all p < 0.001) and in tubulointerstitial injury group (all p < 0.05) than in healthy control group. Meanwhile, sphingomyelin concentrations (SM 18:1/16:0 and 18:1/18:0) in glomerulonephritis group were significantly higher than those in healthy control group (all p < 0.001). Urinary PCs and SMs were positively correlated with proteinuria but negatively correlated with serum albumin. Meanwhile, PCs were positively correlated with serum creatinine. Conclusion: Our work first demonstrated that urinary phospholipids might be biomarkers for the chronic kidney disease patients. Increased urinary phospholipids in chronic kidney disease patients might result from proteinuria, damaged kidney function or proteinuria induced hypoalbuminemia or lipotoxicity.